Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus

被引：0

作者：

Lu QiLin ^{[1
,2
,3
,4
,5
,6
]}

Wang XiaoZhen ^{[1
,2
,3
,4
,5
,6
]}

Xie Wei ^{[1
,2
,3
,4
,5
,6
]}

Chen XiongWei ^{[1
,2
,3
,4
,5
,6
]}

Zhu YiLiang ^{[1
,2
,3
,4
,5
,6
]}

Li XuGui

机构：

[1] ChinaDepartmentofOrthopedics

[2] DepartmentofOrthopedics

[3] Hubei430065

[4] Hubei672OrthopaedicsHospitalofIntegratedChinese&WesternMedicine

[5] HubeiUniversityofChineseMedicine

[6] Wuhan

来源：

中华医学杂志英文版 | 2020年 / 133卷 / 05期

关键词：

D O I：

暂无

中图分类号：

+ [];

学科分类号：

摘要：

<正>To the Editor: Lumbar spinal canal stenosis (LSCS) is a common disease among older individuals. Hypertrophic lumbar ligamentum flavum (LLF) plays a vital role in the pathogenesis of LSCS. The physiolo

引用

页码：623 / 624-625

共 50 条

[41] Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study
Shemesh, Shai
Sidon, Eliezer
Kaisler, Efrat
Sheinis, Dimitry
Velkes, Steven
Ohana, Nissim
Benayahu, Dafna
EUROPEAN SPINE JOURNAL, 2018, 27 (07) : 1614 - 1622
[42] Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study
Shai Shemesh
Eliezer Sidon
Efrat Kaisler
Dimitry Sheinis
Steven Velkes
Nissim Ohana
Dafna Benayahu
European Spine Journal, 2018, 27 : 1614 - 1622
[43] Angiopoietin-Like Protein 2 Induced by Mechanical Stress Accelerates Degeneration and Hypertrophy of the Ligamentum Flavum in Lumbar Spinal Canal Stenosis
Nakamura, Takayuki
Okada, Tatsuya
Endo, Motoyoshi
Kadomatsu, Tsuyoshi
Taniwaki, Takuya
Sei, Akira
Odagiri, Haruki
Masuda, Tetsuro
Fujimoto, Toru
Nakamura, Takafumi
Oike, Yuichi
Mizuta, Hiroshi
PLOS ONE, 2014, 9 (01):
[44] Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia
Morsi, Heba Kamal
Ismail, Manar Mohammad
Gaber, Hassan Abdelaziz Hassan
Elbasmy, Amani Abdelhamid
MEDIATORS OF INFLAMMATION, 2016, 2016
[45] High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus
Mueller, Karin A. L.
Rath, Dominik
Schmid, Martina
Schoenleber, Heiko
Gawaz, Meinrad
Geisler, Tobias
Mueller, Iris I.
CLINICAL CARDIOLOGY, 2016, 39 (04) : 201 - 206
[46] Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes
Cvetkovic, I
Al-Abed, Y
Miljkovic, D
Maksimovic-Ivanic, D
Roth, J
Bacher, M
Lan, HY
Nicoletti, F
Stosic-Grujicic, S
ENDOCRINOLOGY, 2005, 146 (07) : 2942 - 2951
[47] Neutralization of Macrophage Migration Inhibitory Factor activity, reduces local inflammation during Type I diabetes development
Cvetkovic, Ivana
Maksimovic-Ivanic, Danijela
Miljkovic, Djordje
Nicoletti, Ferdinando
Al-Abed, Yousef
Stosic-Grujicic, Stanislava
INFLAMMATION RESEARCH, 2005, 54 : S193 - S193
[48] Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice
Bojunga, J
Kusterer, K
Bacher, M
Kurek, R
Usadel, KH
Renneberg, H
CYTOKINE, 2003, 21 (04) : 179 - 186
[49] The Regulation of HSL by Macrophage Migration Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Obesity
Chen, Liujun
Huang, Yiheng
Li, Lisha
Zabihi, Haleh
Qi, Yadan
Leng, Lin
Sun, Guang
Bucala, Richard
Qi, Dake
DIABETES, 2021, 70
[50] Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas
Lee, Hanna
Rhee, Hwanseok
Kang, Hyun Ju
Kim, Hyon-Suk
Min, Byung Soh
Kim, Nam Kyu
Kim, Hoguen
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (05) : 772 - 779

← 1 2 3 4 5 →